Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...

周二，美银证券分析师重申对Vertex股票 (NASDAQ: VRTX)的买入评级，并维持567.00美元的目标价。Vertex是生物技术行业的重要参与者，市值达1144亿美元。根据 InvestingPro 数据，分析师对Vertex的目标价范围从330美元到621美元不等，目前股价为445.43美元。此决定是在Vera ...

Vertex Pharmaceuticals is the global leader in cystic fibrosis treatment -- and that’s set to continue thanks to the ...

An entrepreneur rolled out his prototype solar-powered car, named INTI, after the Inca sun god. But will solar cars heat up ...

UBS analyst Eliana Merle reaffirmed a Buy rating and a $582 price target for Vertex Pharmaceuticals, praising the adoption of ...

Eli Lilly has reached a deal to acquire SiteOne Therapeutics that would give it control of a non-opioid pain drug that would ...

Tasmea (ASX:TEA) has executed a share purchase agreement to acquire electrical services company Vertex Group.

Get Honey for FREE today ▸ <a href=" Honey finds coupons with one click. Thanks to Honey for sponsoring! Keyboard build ...

The U.S. equity market has been anything but calm in 2025, as several factors, including persistent trade tensions, rising ...

Three Motley Fool contributors believe they've found no-brainer healthcare stocks to buy in June. (Amgen): One of the best ...

This was the stock's second consecutive day of gains.